Okay, thanks, Clive. So I'll start - I will walk us through the three - the results for the quarter, some commentary on year to date, and then just how we see the year panning out. So firstly, on the quarter, revenues of 511 million, so that was based on the sale of 287,000 ounces, at an average released price in the quarter of $1,782. So year-to-date, our average released price for sales is $1,794 per ounce, so very close to that $1,800 price that we've been - that we used just to put out our cash flow guidance so really reinforces that we're still on track there. On the production side, good production quarter, we were on a consolidated basis, including our share of calendar results, total production was 310,000 ounces, which is 21,000 ounces, ahead of budget where we thought it would be and the reasons for that are really the same as we talked about in the earlier quarters in the year. Fekola is still a production machine, there's higher melt throughput going through there, closer to 8.4 million tons annually, so far this year versus the 7.7 5 million tons that we assumed in the budget. And now that Fekola is using - are pulling some low grade material from the stock falls into fill that additional production mill feed, so we can see slightly lower grade overall going through the mill but production is up. So for the quarter Fekola, 166,000 ounces beat budget by 10,000 ounces. Masbate, 61,000 ounces in the Q3, 1000 pounds is better than budget. Aain Masbate just continues to outperform the model with better grades and better recoveries than the model shows, so that's a good positive difference. Now there was - but the highlight and we did mention it in the MD&A and the news release, we didn't mind slightly out of sequencing as Masbate for this quarter. Some of the higher grade main vein material that was originally scheduled for Q4 was mined and produced in the third quarter, so you will see some of that clawed back in the fourth quarter as we go forward. But we did - because we had that additional production and better output from the mill in the quarter, we did take the opportunity just to accelerate some mil maintenance in the queue. In Otjikoto, 69,000 ounces, 2000 ounces ahead of budget and it's just everything is slightly better than budget, so just very solid production all around from Otjikoto. And if you translate that and look at how we did on the cost site, very positive, so consolidate including estimated attributable results for Calibre $445 an ounce was exactly on budget and so good results there. And if you look at that high level big picture, what we're seeing is that there is cost inflation across the sites, just because of the environment we are in. Fuel costs are up, some shipping costs are up, some reagent costs are up but at the same time, we had stronger production, better production, and that really helped to offset those additional, higher costs. So we really came up pretty neutral and right on budget. Through your models, if you want to know on the fuel side, it's probably up about $25 an ounce year to date, I would say, on fuel. But remember, we also have a fuel hedging program in place, so the derivative gains have offset at least half of that we think as we go through the year. So we're pretty solid on fuel, I think. And then the other thing that did impact Otjikoto results in the quarter was stronger Namibian dollar. We budgeted at 16.5 to the US dollar, it's coming in somewhere around 14.5, so probably had an impact of like 45 bucks an ounce year to date on those costs. But like they say the benefit of higher production really has managed to offset most of the cost increases. So when we look at all-in sustaining costs, year-to-date consolidated again, including our share of Calibre, $795 an ounce which is just $14 over budget, so really right on budget in the scheme of things. And the story there is sort of the same, so we have cash costs that are on budget. We do have higher royalties in the quarter and year-to-date, because we originally budgeted $700 gold and we've come in, as I mentioned, very close to $1,800 goal so far, so royalties are higher. But that is offset by higher production and it's also offset by the fact that some of our CapEx has been pushed forward into the fourth quarter. So we did have lower sustaining capital in the quarter and year to date. And those expenditures are really mostly as a result of timing. And we do expect them to be caught up in the fourth quarter. We're forecasting that will happen. Turning to the nine months, very brief commentary on the nine months results, so production year-to-date, 699, including our share of Caliber 743,000 ounces, so 49,000 ounces ahead of budget. So and I'll tell them where we were going to be for the year in a second, but very solid, and for the same reasons I described for the quarter. And then on the on the cost side for that production, so cash cost produced $556 an ounce consolidated, includes share of caliber, which is $14 less than budgets around budget for the same reasons as the quarter. And then all in sustaining costs $900 consolidated per ounce sold, including our share of Caliber, and that's $45 lower than budget. And the reason for that $45 lower than budget really is mainly just the timing of CapEx. So where are we for the year, we did put up some revised production guidance for the year based on where we are today. So our original consolidated guidance, including share of caliber was 970,000 to 1,030,000 ounces. We've bumped that up now to 1,015,000 ounces - between 1,015,000 ounces, and 1,055,000 ounces and the bounce came in from Fekola. The whole range of the guidance was previously 530,000, we'd never counted up to between 560,000 and 570,000 ounces just because Fekola has performed so well. And then Masbate also because we had - we've outperformed in the year, originally 200,000 to 210,000 ounces, we bumped that up to 215,000 to 225,000. Now remember though, that part of that big up performing Q3 was the last minute out of sequence, so we will see a little bit of that caught back in the fourth quarter and so that's why we ended up with a guidance range for Masbate of 215 to 225. Then we look at the cost side of things, we looked at all our guidance and what we see based on what I mentioned about some cost inflation but offset by higher production and the benefit of some derivative gains is that we think for cash costs, we are going to come in within our overall guidance range from the year of $500 to $540 per ounce. If you looked at the individual sites in there, Fekola probably come in at the upper end of that just because it's putting more high grade or lower grade material through higher volumes of low grade material. But the other two sites we think will be certainly just right in the middle of the ranges. And then on the all in sustaining cost side, again, our original guidance was $830 to $910 per ounce and these are including our share of Caliber. We still think we'll be in that range, but we think we'll be on a consolidated basis at the upper end of the guidance, and that has some offsetting factors in it. For Fekola, we've got it - we think it will be at the upper end of the all-in guidance range that we gave, again, because of the nature of the low-grade material going through. At Masbate, we think we may be at or below the low end of the range just because of the production we have to date. And at Otjikoto, just depending on the timing of sales, as we go through the end of the year, we may be at or slightly above the upper end of the guidance range. But overall, for all in sustaining costs, we think we'll be at the upper end of the range. We think that's pretty good testament, I think, to pretty good and a very good testament reflects of how all the sites have performed because we are in inflationary cost environment. And I think just seeing that across the reporting that's going out across the industry right now. But even despite of that, and because of the production that we've managed to pull forward and be against budget, we think we're going to meet those ranges. Let me give a few other thoughts just on where we are, so just general comments on some of the operations as well just as we go through. So Fekola, just to remind you that that the mill really is performing so well now and we've said that we expect it to be somewhere in the 8.3 million, maybe 8.4 billion tons range annualized for 2021 and as we go over a life of mine long term, including feeding some saprolite, material through the mill, we might think we may be able to manage 9 million tons per annum for Fekola. Reminder to that we now started pulling Cardinal into the mine plan, we started developing that in Q3 and we've got some production that coming from Cardinal. We did get permit to do that as part of the overall - well, it's really as part of the overall Fekola permit but we got we got our environmental assessment done and approved by the authority. So we think Cardinals over the longer term can benefit the overall production at Fekola somewhere around the 60,000 ounces a year for the next six to eight years, based on the results that we drilled there and the inferred resources that we've drilled there already. [indiscernible] just remind you to that is now complete up and running and really the overall benefit of that is it allows us to hold back some of the spinning reserves that we have whether gensets there, and the net impact on costs overall is probably matched and reduced Fekola's total cash - overall cash costs by about 3% because it reduces the amount of the cost of our milling - power costs for milling. Otjikoto, on Wolfshag the underground continues and still scheduled to get in and get some more from that underground development by the end of Q1 next year. Work in Gramalote continues. Work continues on the feasibility, both to drill out some of the remaining efforts at the site and also to update the engineering and look at the revised permitting required to move that project forward. We're still expecting to have an update on new feasibility study sometime around the middle of next year. And then Burkina Faso, Clive alluded to that, in the period, we sold 81% interest in the Kiaka project, so we signed the deal and that deal is expected to close right about the end of November. And in conjunction with that, we also updated the previous deal that we had to sell West Africa our interest in the [indiscernible] project. So for Kiaka, the consideration for that deal is that we expected 45 million in half cash, half shares in West Africa on closing, which is, as I said, expected by the end of November. Then another 45 million cash and shares with our option sometime next year, certainly no later than a year from when we close the deal. And then we retain our interest as well as any shares that we might take by retaining a royalty in the project. So, two points of our shares, two points of milling [ph], 2.7% royalty on the first 2.5 million ounces produced from Kiaka and then 0.45% royalty for the next 1.5 million ounces produced. And then just to remind you to that in conjunction with revising [indiscernible] deal with the closing of that deal, deal enters another $9 million tranche, original option payment that will be due now with closing the deal at the end of November when the deal closes as well. So we can expect to see that in Q3. And let me just on the earning side, the GAAP our share - GAAP earnings $0.12 per share, our share adjusted for the quarter $0.12 per share as well. Then year-to-date, our share of GAAP earning $0.27 per share and our share adjusted EPS $0.26 per share. And a couple of comments on the on the cash flow statement, so we have an excellent quarter for generating operating cash flow in the period. 320 million, which certainly be our expectations and that was - that translated to $0.30 per share, operating cash flow. And you know that be is in part due to the fact that we produced and sold more ounces than we'd originally forecast, which is great. Oil price behaved itself first during the quarter and we also had the benefit of some working capital movement changes that went through there that actually benefited cash flow. So, in the end, 320 million for the quarter. Now, we had guided before for the half year, for 2021 second half, we do somewhere around 500 million. We bumped that slightly in our guidance that we put out there. At the end of this quarter, we're now seeing somewhere around 510 million for the half year, so you can expect somewhere between 190 million, 200 million operating cash flow therefore for Q4, as we claw back some of those working capital changes that we benefited from in Q3 and we make some year-end tax payments that are required. Our total tax - cash tax guidance 380 million for the full year remains unchanged, so just remind you that. On the investing side, for the quarter, we were only probably about 6 million under budget with some pluses and minuses across the site. I will say that for the year-to-date on the investing side, just over 200 million, we're probably about 35 million under budget. As I mentioned when discussing the all-in cost, we are behind them some of the sustaining CapEx through the piece. And we're also - we haven't spent as much as originally budgeted yet on some areas like exploration but we do expect that we're going to catch up those CapEx cost by the end of the year. So what we've guided overall for CapEx, if you look in the MD&A would give you some guidance there. For sustaining CapEx, we're probably going to be about 10 million over all-in for the year, which is fractional based on the total sustaining CapEx that we have. And then for non-sustaining, probably also about 10 million over budget, overall for the year, but the main component of that being just some cost for Cardinal, some development and fleet cost for Cardinal, which weren't originally budgeted because we didn't have Cardinal in the original budget. We ended the quarter - we paid dividend in the quarter of $0.04 per shares US and annualized $0.16 per share, which still puts us up somewhere 3.7% to 4% over the [indiscernible] dividend yield, which still one of the highest in the industry. And, we still are maintaining the line there and our intent is to keep paying at that level. And end of quarter - we ended the quarter with $546 million in the bank, so very solid, and we've still got 600 million available on the revolver and that's strong right now. So I think those are the highlights, just what I wanted to emphasis. So just as a reminder to the operating cash flow for the year, we think we're going to come in around 650 million. We had originally guidance 630 but with the better beat that we have so far on the production and revenues offset by some higher costs that we see inflation pass through the year, we think overall, we're going to come in somewhere in 650 million for operating cash with approximately 190 million to 200 million of that in Q4. And that's my update.